AbbVie (ABBV) Current Deferred Tax Assets (2012 - 2015)

AbbVie (ABBV) has 4 years of Current Deferred Tax Assets data on file, last reported at $1.1 billion in Q3 2015.

• Current Deferred Tax Assets for Q3 2015 came in at $1.1 billion, up 109.92% year-over-year; the trailing twelve-month figure through Sep 2015 was $1.1 billion (up 109.92% YoY), and the FY2014 annual result was $896.0 million, up 16.97% from the prior year.
• Current Deferred Tax Assets declined to $1.1 billion in Q3 2015 per ABBV's latest filing, from $1.2 billion in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $1.4 billion in Q2 2013 and troughed at $524.0 million in Q3 2014.
• A 4-year average of $1.1 billion and a median of $1.1 billion in 2014 frame the typical range for Current Deferred Tax Assets.
• The sharpest annual moves came in 2014 and 2015: Current Deferred Tax Assets slumped 63.07% in 2014, then soared 109.92% in 2015.
• A 4-year view of Current Deferred Tax Assets shows it stood at $669.0 million in 2012, then increased by 14.5% to $766.0 million in 2013, then grew by 16.97% to $896.0 million in 2014, then rose by 22.77% to $1.1 billion in 2015.
• Business Quant data shows ABBV's Current Deferred Tax Assets at $1.1 billion in Q3 2015, $1.2 billion in Q2 2015, and $1.1 billion in Q1 2015.